Status:
COMPLETED
Study to Evaluate the Effect of Food on the Pharmacokinetics of ASC41 in Healthy Volunteers
Lead Sponsor:
Gannex Pharma Co., Ltd.
Collaborating Sponsors:
Hunan Provincial People's Hospital
Conditions:
Healthy
NAFLD
Eligibility:
All Genders
18-45 years
Phase:
PHASE1
Brief Summary
This study is to evaluate the effect of food on the pharmacokinetics of a single dose of ASC41 tablet in healthy volunteers, comparing fasting and postprandial pharmacokinetic parameters of Tmax, Cmax...
Eligibility Criteria
Inclusion
- Key
- 19kg/m2 ≤ BMI \<40kg/m2.
- Key
Exclusion
- A history of thyroid disease.
- History of, or current liver disease.
Key Trial Info
Start Date :
December 27 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 21 2021
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04692025
Start Date
December 27 2020
End Date
January 21 2021
Last Update
September 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hunan provincial people's hospital
Changsha, Hunan, China